Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALVAGE
2024-517342-33-01Phase 2Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of omega-3-acid triglycerides in aortic stenosis (AS), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in aortic valve calcium at 24 months. Planned start Sep 2024; status: authorised.
02
Drugs
omega-3-acid triglycerides
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2024-517342-33-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517342-33-01.